http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6875773-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate | 1999-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_befca63dc82d44b208e85e57569bfe73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9bb03f7a034008928a1e265c6bd3c93 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8faa78c639b632f7e87c24937b2ba8c9 |
| publicationDate | 2005-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6875773-B1 |
| titleOfInvention | Combination therapy for treatment of FIV infection |
| abstract | The present invention pertains to methods for therapeutic and prophylactic treatment of cats against FIV infection. Methods of the present invention utilize a combination of antiretroviral compounds to treat or prevent FIV infection in a feline animal. In one embodiment, the method comprises administering an effective amount of AZT and another nucleoside analog, such as, for example, 3TC to the animal. In another embodiment, cats are given an effective dose(s) of AZT, 3TC, and a retroviral protease inhibitor. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009197827-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005159389-A1 |
| priorityDate | 1998-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 112.